XML 64 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1
Product Sales (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Revenue Disclosure [Line Items]        
Net product sales $ 3,718,463 $ 3,338,390 $ 2,689,478  
Activity of Sales Related Deductions [Roll Forward]        
Balance 85,302 45,851 55,249 $ 24,781
Provision related to current period sales 408,270 278,304 193,190  
Credits/payments (368,819) (287,702) (162,722)  
Rebates and Chargebacks        
Activity of Sales Related Deductions [Roll Forward]        
Balance 29,840 12,712 6,419 3,083
Provision related to current period sales 167,755 93,385 61,124  
Credits/payments (150,627) (87,092) (57,788)  
Distribution Related Fees        
Activity of Sales Related Deductions [Roll Forward]        
Balance 34,142 29,465 48,313 21,166
Provision related to current period sales 194,132 154,477 122,466  
Credits/payments (189,455) (173,325) (95,319)  
Other Sales Related Deductions        
Activity of Sales Related Deductions [Roll Forward]        
Balance 21,320 3,674 517 $ 532
Provision related to current period sales 46,383 30,442 9,600  
Credits/payments (28,737) (27,285) (9,615)  
EYLEA        
Revenue Disclosure [Line Items]        
Net product sales 3,701,917 3,323,081 2,676,040  
ARCALYST        
Revenue Disclosure [Line Items]        
Net product sales $ 16,546 $ 15,309 $ 13,438  
Besse Medical | Customer concentration risk | Gross Sales Revenue        
Risks and Uncertainties [Abstract]        
Concentration risk, percentage 51.00% 55.00% 67.00%  
McKesson Corporation | Customer concentration risk | Gross Sales Revenue        
Risks and Uncertainties [Abstract]        
Concentration risk, percentage 29.00% 28.00% 26.00%  
Curascript SD | Customer concentration risk | Gross Sales Revenue        
Risks and Uncertainties [Abstract]        
Concentration risk, percentage 19.00% 16.00%    
Curascript SD | Minimum [Member] | Customer concentration risk | Gross Sales Revenue        
Risks and Uncertainties [Abstract]        
Concentration risk, percentage 10.00% 10.00% 10.00%  
Curascript SD | Maximum [Member] | Customer concentration risk | Gross Sales Revenue        
Risks and Uncertainties [Abstract]        
Concentration risk, percentage     10.00%